Despite share price gain, progress may not be reflected in E...
Despite share price gain, progress may not be reflected in EPS. Recorded TSR loss of 2% per year over last five years hints at potential risks, despite promising shareholder returns.
The One-year Decline in Earnings Might Be Taking Its Toll on Zhejiang CONBA PharmaceuticalLtd (SHSE:600572) Shareholders as Stock Falls 5.0% Over the Past Week
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
3444Followers
0Following
8256Visitors
Follow